By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
No open-market selling at Tenax Therapeutics, Inc. in the past year, which is unusual. Instead eight corporate insiders picked up about $5.1 million worth of TENX.
The largest purchase came from ADAR1 Capital Management, LLC (10% Owner), about $1.6 million. That includes C-suite money, which tends to get the most attention.
Big money check: 111 institutions held TENX as of Q2 2026, and more funds bought than sold. Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters.
Are insiders buying or selling TENX stock?
In the last 12 months Tenax Therapeutics, Inc. insiders made open-market purchases worth about $5.1 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in TENX?
The most recent open-market insider trade in TENX was filed on 2026-09-17.
How many institutions own TENX?
111 investment managers reported holding TENX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded TENX?
No congressional trades in TENX were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).